2024年6月24日 · Zyclara (imiquimod) is used to treat actinic keratoses on the face or balding scalp and external genital warts. Includes Zyclara side effects, interactions and indications.

2024年9月26日 · Zyclara (imiquimod) Cream, 2.5% or 3.75% is an immune response modifier used to treat actinic keratoses of the face or balding scalp. Zyclara Cream is also used to treat external genital and perianal warts in people 12 years and older. What Are Side Effects of Zyclara? Common side effects of Zyclara Cream include: headache,

2024年10月6日 · Zyclara package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

2024年6月3日 · Topical imiquimod is used to treat abnormal skin growths such as actinic keratosis (a type of precancerous growth), superficial basal cell carcinoma (a type of skin cancer), and genital warts...

2024年3月10日 · Easy-to-read patient leaflet for Imiquimod Cream (Zyclara). Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content

ZYCLARA Cream, 2.5% and 3.75% are indicated for the topical treatment of clinically typical visible or palpable, actinic keratoses (AK) of the full face or balding scalp in immunocompetent adults.

2024年10月2日 · ZYCLARA - ® (imiquimod) cream, for topical use ... 1.1 Actinic Keratosis - ZYCLARA, 2.5% and 3.75% are indicated for the topical treatment of clinically typical, visible or palpable actinic keratoses (AK) of the face or balding scalp in ... 2.1 Important Dosage and Administration Instructions - ZYCLARA is for topical use only.

2020年2月16日 · What is Zyclara used for? Zyclara is used to treat genital warts. It is used to treat perianal warts. Zyclara is also used to treat skin harmed by the sun and some skin cancers.

What is Zyclara and what is it used for? Zyclara is a cream used to treat actinic keratosis on the face and balding parts of the scalp. Actinic keratosis is a precancerous, abnormal skin growth that develops after too much exposure to sunlight.

2024年10月2日 · ZYCLARA, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age and older. ZYCLARA is for topical use only. ZYCLARA is not for oral, ophthalmic, intra-anal or intravaginal use. Instruct patients on proper application technique.